DGAP-News: MediClin AG / Key word(s): Interim Report MediClin AG: Group sales in the first nine months of 2011 increased by 1.3 percent - Group result below previous year's figure due to higher expenses and investments and restrained development in the post-acute segement 10.11.2011 / 08:57 --------------------------------------------------------------------- Offenburg, November 10, 2011 - MEDICLIN Aktiengesellschaft (MediClin) has achieved Group sales of EUR 367.7 mill. (9 M 2010: EUR 363.0 mill.) in the first nine months of 2011, thus being EUR 4.7 mill. or 1.3% more than in the comparable previous year's period. The Group's operating result of this period of EUR 7.0 mill. was EUR 5.1 mill. below the previous year's value. Across all segments this decrease in operating result was caused by expenses that increased more than sales and occupancy rates in the post-acute segment, which were lower in comparison to the high level of the same period last year. In the reporting period capital expenditure was EUR 24.0 mill. (9 M 2011: EUR 17.5 mill.). Cash and cash equivalents per September 30, 2011 amounted close to EUR 47.0 mill., equity ratio was 48.0%. The result attributable to the shareholders of MEDICLIN Aktiengesellschaft amounted to EUR 0.6 mill. (9 M 2010: EUR 6.2 mill.). Development of the segments Sales in the post-acute segment increased by EUR 1.1 mill. or 0.6% up to EUR 207.1 mill. (9 M 2010: EUR 206.0 mill.) compared to the previous year's value. Segment result was EUR 0.2 mill. (9 M 2010: EUR 5.2 mill.). Against last year the slight increase in sales could not compensate the higher expenses including depreciation of about EUR 7.7 mill. Sales in the acute segment increased by EUR 2.6 mill. or 1.8 % up to EUR 150.7 mill. (9 M 2010: EUR 148.1 mill.) in the nine-month comparison. The segment result of EUR 12.6 mill. (9 M 2010: EUR 12.7 mill.) was on par with last year, despite higher expenditures. The nursing care business area continued to develop positively. Here, sales rose from EUR 8.3 mill. to EUR 8.8 mill. During the reporting period, occupancy rates were calculated at 94.8 % and were thus 3.6 percentage points above the previous year's value. Outlook Thus far in 2011 lower indication-based benchmarks on the average length of patient stay in the rehabilitation sector enacted at the end of 2010 by the German statutory pension insurance scheme, as well as a lower number of patients, have had a diminishing effect on the number of nursing days in post-acute segment. Particularly the demand for services assigned to curative treatment is in decline. In nearly all medical indications, the demand on the part of the social security pension funds for services involving subsequent nursing treatments was almost at the same level as last year. In the post-acute segment, these constitute more than 60 % of the provided medical services - calculated on the basis of nursing days. As the noticeable chance in the occupancy behaviour of the social security pension funds, observed during the first half of 2011, has continued into the second half of 2011, the operating result for the 2011 financial year will be affected, despite countermeasures taken. At present, an operating result in the upper single-digit range is expected. The interim report as of September 30, 2011 is available under www.mediclin.de in German and English. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,300 employees.. End of Corporate News --------------------------------------------------------------------- 10.11.2011 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG OkenstraÃe 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: alexandra.muehr@mediclin.de Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 145619 10.11.2011
DGAP-News: MediClin AG: Group sales in the first nine months of 2011 increased by 1.3 percent - Group result below previous year's figure due to higher expenses and investments and restrained development in the post-acute segement
| Source: EQS Group AG